We are selling the world leading online astrology platform with 130 million yearly visits and 3m EBITDA. Virtual company not bound to any location. Contact our M&A team for details (project managers: Jürg Kurmann and Claudia Halasz).
Hoffmann & Partner AG has advised Eulitha AG as the lead financial advisor on the transaction with the European-Asian private equity firm AGIC Capital.
We congratulate Eulitha, the leading provider of non-contact Nano-UV-Lithography equipment, for this significant transaction, which enables Eulitha to further strengthen its growth. Read more
Hoffmann & Partner AG has advised Fema Retail AG on the acquisition of Ladenbau Schmidt AG. We are pleased to have accompanied this successful succession process.
Ladenbau Schmidt AG has been in the shop fitting business for over 35 years. The company plans and designs unique spaces for grocery shops, specialist markets, bakeries, cafes, restaurants, hotels, petrol station shops or company reception areas. With aesthetic...
The meaning of preferential rights embedded in preferred shares and empirical evidence in Switzerland
Start-ups in the Life Sciences field are frequently financed through a combination of equity securities with different rights to its holders. There are several economic rationales behind preferred rights for large investors. Whereas certain (e.g. non-participating)...
Kinarus Announces Signing of a Transaction Agreement with Perfect Holding
The private company, Kinarus AG, Basel and Swiss stock listed Perfect Holding SA, Lausanne have today issued a press release regarding a planned reverse merger. We congratulate both companies and thank Kinarus for the trust in our advisory services to support this...
Anaveon To Raise CHF 110 Million In Oversubscribed Series B Financing
The Hoffmann & Co team congratulate Anaveon to this achievement and is proud to be its financial consultant!
The Hoffmann & Co team is proud to be Nemis Technologies’ financial advisor in this financing round.
NEMIS closes CHF 7.75 million series A funding round to further scale up production and pursue global expansion strategy!
Aurealis Therapeutics and XBiome partner for Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16.
We congratulate our client Aurealis Therapeutics for its collaboration agreement with Xbiome. This is a major milestone for the company !
Geschäftsfahrzeuge: Es ist wieder einfacher ab 1.1.2022
Das Zurverfügungstellen eines Geschäftsfahrzeugs für private Zwecke qualifiziert steuerlich als geldwerte Leistung des Arbeitgebers an den Arbeitnehmer. Diese geldwerte Leistung wird meist mittels pauschaler Abrechnung gegenüber der Steuerverwaltung deklariert. Mit...
Buchhalterische und steuerliche Behandlung von FUSIONEN UND ÜBERNAHMEN
Buchhalterische und steuerliche Behandlung von FUSIONEN UND ÜBERNAHMEN Wenn im Rahmen eines Unternehmenskaufs (Asset oder Share Deal) oder einer Umstrukturierung eine Transaktion stattfindet, muss zwangsläufig ein Wert des Kaufobjekts oder des Targets ermittelt...